No CrossRef data available.
Published online by Cambridge University Press: 05 December 2011
Recent advances in our understanding of the receptor components involved in the initial events of oestradiol action are reviewed with an emphasis on aspects of clinical relevance. Two main features of the models have evolved: (1) the domain structure of the ligand-binding unit, with distinct parts of the molecule being concerned with oestrogen-binding and interaction with DNA, and other parts of the molecule having important regulatory functions; (2) the regulatory regions (oestrogen-response elements) of oestrogen-sensitive genes which specifically interact with the receptor protein.
The homologies between different proteins capable of binding ligands as diverse as oestradiol, retinoic acid and thyroid hormone point to possible interactions between such ligands. Oestrogen-response elements can recognise oestradiol receptor proteins complexed with either agonists or antagonists. Interactions with DNA may play an important rôle in determining gene expression additional to those seen at the receptor level.